ArticlebioRxiv : the preprint server for biology2025
HIV-1 Amplifies IL-8 Response of Human Stellate Cells to Gram-Positive Microbial Products Via H4K5 Histone Acetylation.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
10 authors.
Funding
Abstract
Background: Patients living with human immunodeficiency virus 1 (PLWH) develop accelerated liver fibrosis, but the exact mechanism remains unknown. Activation of hepatic stellate cells (HSCs)-a cornerstone of fibrosis-is influenced by various factors, including viral infection, hepatocellular injury, chronic immune activation, gut barrier dysfunction, and microbial translocation. The role of gram-positive microbial products in human immunodeficiency virus 1 (HIV-1) infection-associated liver inflammation and fibrosis remains poorly understood. This study investigates the effect of lipoteichoic acid (LTA), a major gram-positive bacterial component, on HSCs in the context of HIV-1 infection. Methods: Human HSCs were isolated from liver tissues of both HIV-1-infected and uninfected individuals undergoing hepatic resection. Inflammatory responses of HSCs to LTA stimulation were measured ex vivo via ELISA before and after HIV-1 Results: LTA modestly induced interleukin-8/CXCL8 (IL-8) production in HSCs, but this response was significantly heightened following HIV-1 exposure. Increased IL-8 levels were also observed in liver tissues from HIV-1-infected patients. In vitro, IL-8 treatment of HSCs elevated α-SMA and COL1A1 expression, implicating IL-8 in fibrosis progression in HIV-1 infection. Transcriptomic analysis pointed to histone acetylation as a key regulator of the IL-8 response of HSCs to LTA during HIV-1 infection. Supporting this, the histone deacetylase (HDAC) inhibitor Trichostatin A (TSA) further enhanced IL-8 expression in HIV-1-exposed HSCs. ChIP-qPCR confirmed that acetylation of histone H4K5 facilitated IL-8 promoter transactivation, sensitizing HSCs to LTA under HIV-1 influence. Conclusions: HIV-1 infection primes HSCs for an exaggerated response to LTA, driven by histone acetylation and resulting in elevated IL-8 production-potentially accelerating liver fibrosis in PLWH. Given the persistence of microbial translocation despite effective antiretroviral therapy, these findings highlight the need for targeted interventions to prevent or mitigate liver fibrosis in PLWH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.